FDA Drug recall D-0123-2018
Vancomycin Hydrochloride for Injection, USP. 750 mg
- FDA Drug
- Class I
- terminated
- Published 2017-12-27
On 2017-12-27 the FDA classified a Class I recall of Vancomycin Hydrochloride for Injection, USP. 750 mg by Pfizer, citing presence of Particulate Matter: glass particulate found in vial.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0123-2018 |
| Classification | Class I |
| Status | terminated |
| Initiated | 2017-08-30 |
| Published | 2017-12-27 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Pfizer |
| Distribution | US |
Product
Vancomycin Hydrochloride for Injection, USP. 750 mg. Sterile Powder. Rx Only. Hospira, Inc., Lake Forest, IL 60045 USA. NDC: 0409-6531-02
Reason
Presence of Particulate Matter: glass particulate found in vial
Identifiers
| ndc | 0409-6531-12 |
|---|---|
| ndc | 0409-6531-02 |
| ndc | 0409-6533-11 |
| ndc | 0409-6533-01 |
| ndc | 0409-6533-21 |
| ndc | 0409-4332-11 |
| ndc | 0409-4332-01 |
| ndc | 0409-3515-11 |
| ndc | 0409-3515-01 |
| code_info | Lot: 632153A; Exp. 03/18 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0123-2018%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.